Nicola di Rienzo

12PUBLICATIONS
85CO-AUTHORS
NanomedicineEpidemiological modellingImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 17, 2026
Real-world outcomes of venetoclax plus hypomethylating agents in unfit acute myeloid leukaemia: Results of the GIMEMA AML2320 trial.

|Aug 05, 2026
Real-world approaches to preventing acute myeloid leukemia relapse after allogeneic transplantation: a national survey by GITMO (Gruppo Italiano Trapianto Midollo Osseo).

|Jul 25, 2026
Real-Life Study on Gilteritinib-Related Infections (GilteRInf): An Italian SEIFEM Study.

|Jun 29, 2025
Chronic myeloid leukemia outcomes according to baseline risk and first-line treatment in real-world settings: Data from the Italian Network/CML Campus.

Valentina Giai, Tiziana Rosso, Fausto Castagnetti

|Mar 22, 2025
INO-CD22: A multicenter, real-world study of inotuzumab ozogamicin safety and effectiveness in adult patients with relapsed/refractory acute lymphoblastic leukemia.

Cristina Papayannidis, Elisabetta Petracci, Patrizia Zappasodi

|Mar 20, 2025
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI).

Massimo Breccia, Francesca Palandri, Maurizio Martelli

Pageof 2

Frequent Collaborators

3 joint publications

Massimo Breccia

3 joint publications

Erika Borlenghi

2 joint publications

Adriano Venditti

2 joint publications

Cristina Papayannidis